Nestor Rubio-Infante

Nestor Rubio-Infante

Auto-generated profile, based on publicly available information

Nestor Rubio-Infante

Tecnológico de Monterrey, The Institute for Obesity Research, Nuevo León, Mexico

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
JVJose R Villarreal-Calderón
Jose R Villarreal-Calderón
RCRicardo X. Cuéllar
Ricardo X. Cuéllar
MRMartin Ramos
Martin Ramos
NRNestor Rubio-Infante
Nestor Rubio-Infante
ECElena C. Castillo
Elena C. Castillo
GGGerardo Garcia-Rivas
Gerardo Garcia-Rivas
Low-grade chronic inflammation plays a pivotal role among other pathophysiological mechanisms involved in obesity. Innate and adaptive immune cells undergo systemic proinflammatory polarization that gives rise to an increased secretion of proinflammatory cytokines, which in turn leads to insulin resistance. Bariatric surgery is currently the most effective treatment for obesity, as it brings on significant weight loss, glucose metabolism improvement, and a decrease in systemic inflammation biomarkers. After bariatric surgery, several changes have been reported to occur in adaptive immunity, including reduction in CD4+ and CD8+ T cell counts, a decrease in the Th1/Th2 ratio, an increase in B regulatory cells, and reduction in proinflammatory cytokine secretion. Overall, there seems to be a major shift in several lymphocyte populations from a proinflammatory to an anti-inflammatory phenotype. Furthermore, increased antioxidant activity and reduced lipid and DNA oxidation products have been reported after bariatric surgery in circulating mononuclear cells. This paper highlights the shift in the adaptive immune system in response to weight loss and improved insulin sensitivity, as well as the interplay between immunological and metabolic adaptations as a result of bariatric surgery. Finally, based on data from research, we propose several mechanisms such as changes in adaptive immune cell phenotypes and their by-products, recruitment in adipose tissue, reduced oxidative stress, and modification in metabolic substrate availability as drivers to reduce low-grade chronic inflammation after bariatric surgery in severe obesity.

17 March 2015 in Molecular Biotechnology
Verified
Journal Article
Open access
PDF file
NRNéstor Rubio-Infante
Néstor Rubio-Infante
DGDania O. Govea-Alonso
Dania O. Govea-Alonso
ARAndrea Romero-Maldonado
Andrea Romero-Maldonado
AGAna Lilia García-Hernández
Ana Lilia García-Hernández
DIDamaris Ilhuicatzi-Alvarado
Damaris Ilhuicatzi-Alvarado
LMLeticia Moreno-Fierros
Leticia Moreno-Fierros
Multi-HIV, a multiepitopic protein derived from both gp120 and gp41 envelope proteins of the human immunodeficiency virus (HIV), has been proposed as a vaccine prototype capable of inducing broad immune responses, as it carries various B and T cell epitopes from several HIV strains. In this study, the immunogenic properties of a Multi-HIV expressed in tobacco chloroplasts are evaluated in test mice. BALB/c mice orally immunized with tobacco-derived Multi-HIV have elicited antibody responses, including both the V3 loop of gp120 and the ELDKWA epitope of gp41. Based on splenocyte proliferation assays, stimulation with epitopes of the C4, V3 domain of gp120, and the ELDKWA domain of gp41 elicits positive cellular responses. Furthermore, specific interferon gamma production is observed in both CD4+ and CD8+ T cells stimulated with HIV peptides. These results demonstrate that plant-derived Multi-HIV induces T helper-specific responses. Altogether, these findings illustrate the immunogenic potential of plant-derived Multi-HIV in an oral immunization scheme. The potential of this low-cost immunization approach and its implications on HIV/AIDS vaccine development are discussed.

3 January 2014 in Expert Review of Vaccines
Verified
Journal Article
Closed access
Sergio Rosales-MendozaSergio Rosales-Mendoza
Sergio Rosales-Mendoza
NRNéstor Rubio-Infante
Néstor Rubio-Infante
SZSergio Zarazúa
Sergio Zarazúa
DGDania O Govea-Alonso
Dania O Govea-Alonso
GMGuadalupe Martel-Gallegos
Guadalupe Martel-Gallegos
LMLeticia Moreno-Fierros
Leticia Moreno-Fierros
Plants are considered advantageous platforms for biomanufacturing recombinant vaccines. This constitutes a field of intensive research and some plant-derived vaccines are expected to be marketed in the near future. In particular, plant-based production of immunogens targeting molecules with implications on the pathology of Alzheimer's has been explored over the last decade. These efforts involve targeting amyloid beta and β-secretase with several immunogen configurations that have been evaluated in test animals. The results of these developments are analyzed in this review. Perspectives on the topic are identified, such as exploring additional antigen configurations and adjuvants in order to improve immunization schemes, characterizing in detail the elicited immune responses, and immunological considerations in the achievement of therapeutic humoral responses via mucosal immunization. Safety concerns related to these therapies will also be discussed.

15 July 2025 in Life Sciences
Verified
Journal Article
Closed access
RLRodrigo López-Velázquez
Rodrigo López-Velázquez
SLSilvia López-Morán
Silvia López-Morán
ARAlicia Ramírez-Rivera
Alicia Ramírez-Rivera
NRNestor Rubio-Infante
Nestor Rubio-Infante
EVEduardo Vázquez-Garza
Eduardo Vázquez-Garza
NGNoemí García
Noemí García

28 April 2022 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
NRNestor Rubio-Infante
Nestor Rubio-Infante
OLOmar Lozano
Omar Lozano
MRMartin Ramos
Martin Ramos
DSDaniel Salas-Treviño
Daniel Salas-Treviño
ASAdolfo Soto-Domínguez
Adolfo Soto-Domínguez
GGGerardo Garcia-Rivas
Gerardo Garcia-Rivas